EMILY FAZIO: Open Payments
NPI 1659025336 · MC MURRAY, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$603 in 16 payments from 7 companies in 2025. Trend: 2023 $265 · 2024 $897 · 2025 $603
Food & beverage: $603
| Company | Payments | Amount |
|---|---|---|
| Regeneron Healthcare Solutions, Inc. | 5 | $152 |
| Olympus America Inc. | 1 | $119 |
| Medtronic, Inc. | 1 | $114 |
| Phathom Pharmaceuticals, Inc. | 4 | $96 |
| GENZYME CORPORATION | 3 | $62 |
| Ethicon US, LLC | 1 | $33 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $27 |
Products named: DUPIXENT, HANAROSTENT Esophagus TTS(CCC), BARRX, VOQUEZNA, LINX REFLUX MANAGEMENT SYSTEM, EOHILIA.
Industry payments across PA — which companies pay providers there.
